A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Axicabtagene ciloleucel (Primary) ; Cyclophosphamide; Fludarabine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms ZUMA-5
- Sponsors Kite Pharma
- 02 Aug 2017 According to a Kite Pharma media release, first patient in this trial has been dosed.
- 08 May 2017 Status changed from not yet recruiting to recruiting, according to a Kite Pharma media release.
- 03 Apr 2017 Status changed from planning to not yet recruiting.